May 23 2013 Venaxis Announces Pricing of Offering of Common Stock and Warrants
May 22 2013 Oligomerix, Inc. Completes Series B Financing
Apr 29 2013 Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering
Baton Rouge Neurologist Touts the Benefits of Axona® in Treating Alzheimer's Disease
